Biotia
Biotia Raises $9M to Close the Diagnostic Gap for Recurrent and Culture-Negative UTIs
Новые раунды инвестиций стартапов из форм D в SEC и технологических новостей. Раундов в базе: 296. Обновлено 15 окт. 2026 г.
Biotia Raises $9M to Close the Diagnostic Gap for Recurrent and Culture-Negative UTIs
Denmark’s Breye Therapeutics raises €67.5 million to advance oral therapies for early treatment of retinal diseases
Sweden’s Omnio raises €2.9 million to advance its plasminogen-based therapy for hard-to-heal chronic wounds
Tiny Health Raises $33M To Explore What Gut Data Can Reveal About Future Health